The growth of Viagra and its impact on the medicinal landscape presents a complicated question for investors. While the initial sales statistics were astounding, the intellectual property has lapsed, leading to a wave of copycat alternatives that are reducing revenue. Moreover, the market is facing difficulties related to population trends and e… Read More